Alpha Analyst | AI for Finance

Ask AI

Analyze my watchlists

Themes, risks, and catalysts across lists.

Summarize any 10-K

Business, risks, and financials from filings.

Compare two companies

Side-by-side on filings and metrics.

Screen for ideas

Filter by fundamentals and filing signals.

Search filings by topic

Find disclosures on any theme or keyword.

Company research briefing

Full profile from SEC filings fast.

Insider activity scan

Form 4 buys, sells, and clusters.

Market briefing today

Macro, sectors, and what matters now.

Latest Key Metrics

Mccormick & Co Inc

Q3 '26 - 08/31/26 (USD)

Revenue: 2,025 MM
EBITDA: 217 MM
Net Income: 97.60 MM
EPS: 0.36

Acuity Inc. (de)

FY '26 - 08/31/26 (USD)

Revenue: 4,642 MM
EBITDA: 714 MM
Net Income: 531 MM
EPS: 17.49

Accenture Public Limited Company

FY '26 - 08/31/26 (USD)

Revenue: 74,183 MM
EBITDA: 11,406 MM
Net Income: 8,523 MM
EPS: 13.66

Micron Technology Inc

FY '26 - 09/03/26 (USD)

Revenue: 133,188 MM
EBITDA: 99,340 MM
Net Income: 84,969 MM
EPS: 75.38

Jabil Inc

FY '26 - 08/31/26 (USD)

Revenue: 35,954 MM
EBITDA: 1,704 MM
Net Income: 1,042 MM
EPS: 9.86

Latest News & Filings

Filings

Bluerock Private Real Estate Fund
4Jordan Ruddy23 Oct
HeartSciences Inc.
SC 13D/AHeartSciences Inc.23 Oct
Natera, Inc.
4Sheena Jonathan23 Oct
Nature's Miracle Holding Inc.
4Adair Kathleen Theresa23 Oct
0001801661
4Statement of changes in beneficial ownership23 Oct
Provectus Biopharmaceuticals, Inc.
4Statement of changes in beneficial ownership23 Oct
Silvia, Inc.
4Statement of changes in beneficial ownership23 Oct
Lion Copper Corp.
SC 13D/ALion Copper Corp.23 Oct

Stock News

PJT US
PJT Partners: Credit Crisis In AI Is A Golden Opportunity02:49AM
ADC US
Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 202602:30AM
IMTX US
Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting02:30AM
ZYME US
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 202602:30AM
SPCX US
Is It Too Late to Buy SpaceX Stock After Its Monster Third-Quarter Earnings Report? Here's the Answer.02:11AM
R US
Ryder: 3 Key Takeaways for Long-Term Investors02:07AM
ARBK US
BlockchAIn Digital Infrastructure Unveils $1B+ Nebius Data Center Lease Strategy02:02AM
P-OPEA
OpenAI Nears $1.25 Trillion Valuation. What That Tells Investors Ahead of a Potential 2027 IPO.01:38AM

Market Signals

Ticker	Last	Change	Volume	Signal

4.97

69.85%

214.25K

1.57

36.63%

210.54K

0.01

34.74%

1.58M

1.08

33.33%

13.70M

12.21

30.06%

1.38M

5.89

0.00%

3.78M

5.89

0.00%

3.78M

15.39

0.00%

1.15M

1,118.09

0.00%

537.74K

39.19

0.00%

5.52M

9.02

5.94%

1.18M

3.32

5.82%

340.58K

0.07

0.96%

200

176.41

-0.98%

382

1.58

4.65%

3.41K

4.50

4.23%

107.00K

1.57

36.63%

210.54K

MACD Bull Cross

7.78

4.28%

1.02M

4.97

69.85%

214.25K

2.15

51.23%

162.06K

2.63

13.35%

121.13K

0.44

5.63%

28.34M

12.21

30.06%

1.38M

1.55

11.62%

1.06M

5.95

8.72%

421.10K

2.68

8.18%

178.00K

1.82

10.08%

117.12K

1.83

9.85%

287.13K

7.03

7.88%

4.95M

0.51

-0.66%

1.19M

0.71

24.52%

406.00K

3.68

19.98%

5.43M

Ticker	Last	Change	Volume	Signal

4.58

-87.71%

717.20K

0.22

-41.32%

2.76M

1.04

-30.56%

3.35M

0.02

-28.57%

246.60K

5.89

0.00%

3.78M

5.89

0.00%

3.78M

15.39

0.00%

1.15M

5.89

0.00%

3.78M

5.89

0.00%

3.78M

4.58

-87.71%

717.20K

1.30

-3.50%

297.50K

0.00

0.00%

18.95B

0.64

-1.28%

1.33B

4.58

-87.71%

717.20K

MACD Bear Cross

0.78

-1.42%

43.90M

12.21

30.06%

1.38M

1.71

15.16%

351.19K

4.00

12.38%

1.20M

22.54

10.22%

368.31K

1.08

33.33%

13.70M

3.52

13.85%

124.50K

9.89

14.52%

610.49K

1.79

11.83%

1.12M

4.00

12.38%

1.20M

36.85

10.13%

2.04M

22.54

10.22%

368.31K

Multiple Bottom

4.70

10.02%

1.71M

Multiple Bottom

7.35

15.50%

9.59M

Head & Shoulders

35.62

15.16%

268.80K

Head & Shoulders

1.45

15.08%

206.20K

Inv. Head & Shoulders

3.27

14.21%

3.55M

Inv. Head & Shoulders